跳至主要内容
临床试验/CTRI/2019/12/022318
CTRI/2019/12/022318尚未招募4 期

A prospective, comparative, randomized clinical study to compare and evaluate the safety, efficacy and refractive outcome of three different Hydrophilic Monofocal Intraocular Lens implanted to cataract patients. - BTVCPL-HFIOL-2019-02

Biotech Vision Care Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Unilateral/Bilateral Cataract
  • 2.Patients with age > 50 years.
  • 3.Patients with Grade I or Grade II cataract as per Lens Opacities Classification System III (LOCS-III).
  • 4.Patients that have healthy eyes excluding the formation of senile cataract.
  • 5.Patient who are ready to attended all the regular follow-up examinations as per the routine schedule.

排除标准

  • 1.Patients receiving Chloroquine treatment.
  • 2.Preoperative corneal astigmatism > 1.
  • 3.Baseline endothelial cell density < 1500 cells/mm2 in the operative eye.
  • 4.Amblyopia, Microphthalmia, Glaucoma, Pseudoexfoliation Syndrome with Glaucoma, Iris atrophy, Proliferative diabetic retinopathy and all retinal pathologies.
  • 5.A history of chronic or recurrent inflammatory eye disease (e.g. iritis, scleritis, uveitis, Iridocyclitis, rubeosis iritis).
  • 6.Previous intra-ocular or corneal surgery.
  • 7.Pregnant or lactating mother.
  • 8.Concurrent participation in another drug or device Study

研究者

发起方
Biotech Vision Care Pvt Ltd

相似试验